Royal Bank Of Canada Boosts American Healthcare REIT (NYSE:AHR) Price Target to $61.00

American Healthcare REIT (NYSE:AHR) had its target price lifted by stock analysts at Royal Bank Of Canada from $56.00 to $61.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target would suggest a potential upside of 13.20% from the stock’s previous close.

A number of other equities analysts also recently commented on the stock. UBS Group upped their target price on shares of American Healthcare REIT from $60.00 to $63.00 and gave the stock a “buy” rating in a research note on Wednesday, July 8th. Citigroup reaffirmed a “buy” rating and set a $65.00 price target (up from $55.00) on shares of American Healthcare REIT in a research note on Monday. Barclays started coverage on American Healthcare REIT in a report on Tuesday, July 7th. They issued an “overweight” rating and a $61.00 price target for the company. KeyCorp raised their price objective on American Healthcare REIT from $55.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Finally, Scotiabank reduced their price objective on American Healthcare REIT from $59.00 to $51.00 and set a “sector outperform” rating on the stock in a report on Thursday, June 18th. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $60.08.

American Healthcare REIT Trading Up 0.5%

Shares of AHR traded up $0.28 during trading hours on Friday, reaching $53.88. 654,461 shares of the company traded hands, compared to its average volume of 2,951,230. The stock’s fifty day moving average price is $52.74 and its 200 day moving average price is $50.90. The company has a current ratio of 0.48, a quick ratio of 0.45 and a debt-to-equity ratio of 0.24. The firm has a market cap of $10.38 billion, a price-to-earnings ratio of 79.27, a PEG ratio of 1.67 and a beta of 0.76. American Healthcare REIT has a 12-month low of $39.68 and a 12-month high of $58.70.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. American Healthcare REIT had a net margin of 4.84% and a return on equity of 3.63%. The company had revenue of $674.25 million for the quarter, compared to the consensus estimate of $645.30 million. During the same quarter last year, the firm posted $0.42 EPS. The firm’s revenue was up 24.3% compared to the same quarter last year. American Healthcare REIT has set its FY 2026 guidance at 2.150-2.190 EPS. Sell-side analysts forecast that American Healthcare REIT will post 2.17 earnings per share for the current year.

Insider Buying and Selling

In other American Healthcare REIT news, CFO Brian Peay sold 25,000 shares of the company’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $50.70, for a total transaction of $1,267,500.00. Following the completion of the sale, the chief financial officer owned 152,700 shares in the company, valued at $7,741,890. This represents a 14.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Mark E. Foster sold 2,500 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $48.58, for a total value of $121,450.00. Following the sale, the executive vice president directly owned 52,995 shares in the company, valued at $2,574,497.10. This trade represents a 4.50% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 29,500 shares of company stock valued at $1,485,590 in the last three months. 0.75% of the stock is currently owned by insiders.

Institutional Investors Weigh In On American Healthcare REIT

A number of hedge funds have recently made changes to their positions in AHR. Manning & Napier Advisors LLC bought a new stake in American Healthcare REIT during the first quarter valued at about $26,000. Garton & Associates Financial Advisors LLC bought a new position in American Healthcare REIT in the fourth quarter worth about $26,000. Kemnay Advisory Services Inc. purchased a new stake in shares of American Healthcare REIT during the fourth quarter valued at about $29,000. Darwin Wealth Management LLC purchased a new stake in shares of American Healthcare REIT during the second quarter valued at about $31,000. Finally, Los Angeles Capital Management LLC bought a new stake in shares of American Healthcare REIT in the 4th quarter valued at about $34,000. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

About American Healthcare REIT

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.